E09.37

Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment

Header / non-billable

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · E09.37
7th character

One of the following 7th characters is to be assigned to code E09.37 to designate laterality of the disease:

Valid 7th characters and their meanings
CharacterMeaning
1right eye
2left eye
3bilateral
9unspecified eye
Inherited from E09Drug or chemical induced diabetes mellitus
Excludes 1

diabetes mellitus due to underlying condition (E08.-) gestational diabetes (O24.4-) neonatal diabetes mellitus (P70.2) postpancreatectomy diabetes mellitus (E13.-) postprocedural diabetes mellitus (E13.-) secondary diabetes mellitus NEC (E13.-) type 1 diabetes mellitus (E10.-) type 2 diabetes mellitus (E11.-)

Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85) insulin (Z79.4) oral antidiabetic drugs (Z79.84) oral hypoglycemic drugs (Z79.84)

Code first

poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

Inherited from chapter 4Endocrine, nutritional and metabolic diseases
Excludes 1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Official Guidelines for E09.37

FY 2026 ›